Institutional investors purchased a net $132.2 thousand shares of IPXL during the quarter ended June 2016 and now own 89.64% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Generic industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
LEGAL & GENERAL INVESTMENT MANAG... Bought 51.3 Thousand shares of Impax Laboratories Inc
APO ASSET MANAGEMENT GMBH Bought 46.0 Thousand shares of Impax Laboratories Inc